These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 25158596)

  • 1. Expression of leptin and its receptor in thyroid carcinoma: distinctive prognostic significance in different subtypes.
    Fan YL; Li XQ
    Clin Endocrinol (Oxf); 2015 Aug; 83(2):261-7. PubMed ID: 25158596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leptin-R and its association with PI3K/AKT signaling pathway in papillary thyroid carcinoma.
    Uddin S; Bavi P; Siraj AK; Ahmed M; Al-Rasheed M; Hussain AR; Ahmed M; Amin T; Alzahrani A; Al-Dayel F; Abubaker J; Bu R; Al-Kuraya KS
    Endocr Relat Cancer; 2010 Mar; 17(1):191-202. PubMed ID: 20008098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of cancer stem cell markers is more frequent in anaplastic thyroid carcinoma compared to papillary thyroid carcinoma and is related to adverse clinical outcome.
    Yun JY; Kim YA; Choe JY; Min H; Lee KS; Jung Y; Oh S; Kim JE
    J Clin Pathol; 2014 Feb; 67(2):125-33. PubMed ID: 23986551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TROP-2 expression in papillary thyroid carcinoma: Potential Diagnostic Utility.
    Simms A; Jacob RP; Cohen C; Siddiqui MT
    Diagn Cytopathol; 2016 Jan; 44(1):26-31. PubMed ID: 26481593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors related to mortality in patients with papillary and follicular thyroid cancer in long-term follow-up.
    de Melo TG; Zantut-Wittmann DE; Ficher E; da Assumpção LV
    J Endocrinol Invest; 2014 Dec; 37(12):1195-200. PubMed ID: 25037473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing the Prognostic Value of the Eighth Edition of the American Joint Committee on Cancer/Tumor Node Metastasis Staging System Between Papillary and Follicular Thyroid Cancer.
    van Velsen EFS; Stegenga MT; van Kemenade FJ; Kam BLR; van Ginhoven TM; Visser WE; Peeters RP
    Thyroid; 2018 Aug; 28(8):976-981. PubMed ID: 29848239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of survival rates between papillary and follicular thyroid carcinomas among 36,725 patients.
    Oyer SL; Fritsch VA; Lentsch EJ
    Ann Otol Rhinol Laryngol; 2014 Feb; 123(2):94-100. PubMed ID: 24574464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression of metadherin correlates with malignant pathological features and poor prognostic significance in papillary thyroid carcinoma.
    Li WF; Wang G; Zhao ZB; Liu CA
    Clin Endocrinol (Oxf); 2015 Oct; 83(4):572-80. PubMed ID: 25418110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eighth edition of tumor-node-metastasis staging system improve survival predictability for papillary, but not follicular thyroid carcinoma: A multicenter cohort study.
    Kim M; Kim HI; Jeon MJ; Kim HK; Kim EH; Yi HS; Kim ES; Kim H; Kim BH; Kim TY; Kim SW; Kang HC; Kim WB; Chung JH; Shong YK; Kim TH; Kim WG
    Oral Oncol; 2018 Dec; 87():97-103. PubMed ID: 30527251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Programmed Death-Ligand 1 (PD-L1) Is a Potential Biomarker of Disease-Free Survival in Papillary Thyroid Carcinoma: a Systematic Review and Meta-Analysis of PD-L1 Immunoexpression in Follicular Epithelial Derived Thyroid Carcinoma.
    Girolami I; Pantanowitz L; Mete O; Brunelli M; Marletta S; Colato C; Trimboli P; Crescenzi A; Bongiovanni M; Barbareschi M; Eccher A
    Endocr Pathol; 2020 Sep; 31(3):291-300. PubMed ID: 32468210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follicular variant of papillary thyroid carcinoma is a unique clinical entity: a population-based study of 10,740 cases.
    Yu XM; Schneider DF; Leverson G; Chen H; Sippel RS
    Thyroid; 2013 Oct; 23(10):1263-8. PubMed ID: 23477346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis of a rare subtype of thyroid cancer: Spindle cell thyroid carcinoma.
    Liu Z; Zhao Q; Zeng W; Wang S; Xiong Y; Guo H; Huang T; Cheng H; Guo L
    Medicine (Baltimore); 2018 Nov; 97(45):e13053. PubMed ID: 30407303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors of papillary and follicular thyroid cancer: differences in an iodine-replete endemic goiter region.
    Passler C; Scheuba C; Prager G; Kaczirek K; Kaserer K; Zettinig G; Niederle B
    Endocr Relat Cancer; 2004 Mar; 11(1):131-9. PubMed ID: 15027890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Bedside Risk Calculator to Preoperatively Distinguish Follicular Thyroid Carcinoma from Follicular Variant of Papillary Thyroid Carcinoma.
    Englum BR; Pura J; Reed SD; Roman SA; Sosa JA; Scheri RP
    World J Surg; 2015 Dec; 39(12):2928-34. PubMed ID: 26324158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.
    Chereau N; Dauzier E; Godiris-Petit G; Noullet S; Brocheriou I; Leenhardt L; Buffet C; Menegaux F
    Langenbecks Arch Surg; 2018 May; 403(3):325-332. PubMed ID: 29445865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The diagnostic significance of trophoblast cell-surface antigen-2 expression in benign and malignant thyroid lesions.
    Sadullahoğlu C; Sayıner A; Süren D; Yıldırım HT; Nergiz D; Sezer C; Oruç MT
    Indian J Pathol Microbiol; 2019; 62(2):206-210. PubMed ID: 30971541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histopathologic Features and Clinical Outcome of Anaplastic Thyroid Carcinoma with a Minor Anaplastic Component.
    Wong KS; Lorch JH; Alexander EK; Marqusee E; Cho NL; Nehs MA; Doherty GM; Barletta JA
    Endocr Pathol; 2020 Sep; 31(3):283-290. PubMed ID: 32445173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas.
    Liu T; Wang N; Cao J; Sofiadis A; Dinets A; Zedenius J; Larsson C; Xu D
    Oncogene; 2014 Oct; 33(42):4978-84. PubMed ID: 24141777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease-free survival in papillary and follicular thyroid carcinoma. Comparison between UICC 5th and 7th classifications of T stage, and the prognostic value of primary tumour size.
    Meixner M; Hellmich M; Dietlein M; Kobe C; Schicha H; Schmidt M
    Nuklearmedizin; 2013; 52(3):71-80. PubMed ID: 23483137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative Expression of CPSF2 Predicts a Poorer Clinical Outcome in Patients with Papillary Thyroid Carcinoma.
    Sung TY; Kim M; Kim TY; Kim WG; Park Y; Song DE; Park SY; Kwon H; Choi YM; Jang EK; Jeon MJ; Shong YK; Hong SJ; Kim WB
    Thyroid; 2015 Sep; 25(9):1020-5. PubMed ID: 26148673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.